Table 3.
Participant demographics and clinical features. Note: Diagnoses missing for one participant in site 3.
| Site 1 | Site 2 | Site 3 | Site 4 | Total | |
|---|---|---|---|---|---|
| N | 8 | 6 | 10 | 6 | 30 |
| Age | |||||
| Range | 58–77 | 56–87 | 56–91 | 59–84 | 56–91 |
| Mean (standard error) | 69.38 (2.764) | 70.5 (5.542) | 68.5 (3.769) | 78.17 (3.894) | 71.07 (1.999) |
| 95% confidence interval | 62.84–75.91 | 56.25–84.75 | 59.97–77.03 | 68.16–88.18 | 66.98–75.15 |
| Gender | |||||
| Male | 5 | 0 | 7 | 3 | 15 |
| Female | 3 | 6 | 3 | 3 | 15 |
| Ethnicity | |||||
| White British | 8 | 5 | 9 | 6 | 28 |
| Asian Ugandan | 0 | 1 | 0 | 0 | 1 |
| Black Caribbean | 0 | 0 | 1 | 0 | 1 |
| Diagnosis | |||||
| Cancer | 2 | 4 | 7 | 3 | 16 |
| Noncancer | 2 | 0 | 1 | 3 | 6 |
| Multimorbidity inc cancer | 4 | 2 | 1 | 0 | 7 |
| Living alone | 1 | 1 | 4 | 2 | 8 |